Arbeitsgebiete
Assayentwicklung, Multiplexe Immunoassays, Bioinformatik, Datenanalyse und -visualisierung
Werdegang mit den wichtigsten Stationen
2019 - heute Wissenschaftler / Doktorand, NMI Reutlingen
2015 - 2018 M.Sc. Biochemie, Universität Tübingen
2012 - 2015 B.Sc. Biochemie, Universität Tübingen
Matthias Becker
Publikationen
-
Cell Type-Specific Anti-Adhesion Properties of Peritoneal Cell Treatment with Plasma-Activated Media (PAM)Holl, M., Rasch, M., Becker, L., Keller, A., Schultze-Rhonhof, L., Ruoff, F., Templin, M., Keller, S., Neis, F., Keßler, F., Andress, J., Bachmann, C., Krämer, B., Schenke-Layland, K., Brucker, S., Marzi, J., Weiss, M.10.3390/biomedicines10040927
-
Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assayJunker D, Dulovic A, Becker M, Wagner T R, Kaiser P D, Traenkle B, Rothbauer U, Kienzle K, Bunk S, Strümper C, Häberle H, Schmauder K, Malek N, Althaus K, Koeppen M, Bitzer M, Göpel S, Schneiderhan-Marra NmedRxiv, https://doi.org/10.1101/2021.08.20.21262328
-
Diminishing immune responses against variants of concern in dialysis patients four months after SARS-CoV-2 mRNA vaccinationDulovic A, Strengert M, Morillas Ramos G, Becker M, Griesbaum J, Junker D, Lürken K, Beigel A, Wrenger E, Lonnemann G, Cossmann A, Stankov M, Dopfer-Jablonka A, Kaiser P, Traenkle B, Rothbauer U, Krause G, Schneiderhan-Marra N, Behrens G M.N.medRxiv, https://doi.org/10.1101/2021.08.16.21262115
-
A broadly neutralizing biparatopic Nanobody protects mice from lethal challenge with SARS-CoV-2 variants of concernWagner T, Schnepf D, Beer J, Klingel K, Ruetalo N, Kaiser P, Junker D, Sauter M, raenkle B, Frecot D, Becker M, Schneiderhan-Marra N, Ohnemus A, Schwemmle M, Schindler M, Rothbauer UbioRxiv, doi: https://doi.org/10.1101/2021.08.08.455562
-
Cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine in patients on haemodialysisStrengert M, Becker M, Morillas Ramos G, Dulovic A, Gruber J, Juengling J, Lürken K, Beigel A, Wrenger E, Lonnemann G, Cossmann A, Stankov M, Dopfer-Jablonka A, Kaiser P, Traenkle B, Rothbauer U, Krause G, Schneiderhan-Marra N, Behrens G M.N.Lancet EBioMedicine, Published: August 11, 2021DOI:https://doi.org/10.1016/j.ebiom.2021.103524
-
Typically asymptomatic but with robust antibody formation: Children’s unique humoral immune response to SARS-CoV-2.Renk H, Dulovic A, Becker M, Fabricius D, Zernickel M, Junker D, Seidel A, Groß R, Hilger A, Bode S, Fritsch L, Frieh P, Haddad A, Görne T, Remppis J, Ganzemueller T, Dietz A, Huzly D, Hengel H, Kaier K, Weber S, Jacobsen EM, Kaise P, Traenkle B, Rothbauer U, Stich M, Tönshoff B, Hoffmann H, Müller B, Ludwig C, Jahrsdörfer B, Schrezenmeier H, Peter A, Hörber S, Iftner T, Münch J, Stamminger T, Groß HJ, Wolkewitz M, Engel C, Rizzi M, Henneke P, Franz AR, Debatin KM, Schneiderhan-Marra N, Janda A, Elling RmedRxiv, doi: https://doi.org/10.1101/2021.07.20.21260863
-
NeutrobodyPlex - monitoring SARS-CoV-2 neutralizing immune responses using nanobodiesWagner TR, Ostertag E, Kaiser PD, Gramlich M, Ruetalo N, Junker D, Haering J, Traenkle B, Becker M, Dulovic A, Schweizer H, Nueske S, Scholz A, Zeck A, Schenke-Layland K, Nelde A, Strengert M, Walz JS, Zocher G, Stehle T, Schindler M, Schneiderhan-Marra N, Rothbauer UEMBO Rep. 2021 May 5;22(5):e52325. doi: 10.15252/embr.202052325. Epub 2021 Apr 27. PMID: 33904225; PMCID: PMC8097376.
-
Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2Fink S., Ruoff F., Stahl A., Becker M., Kaiser P., Traenkle B., Junker D., Weise F., Ruetalo N., Hörber S., Peter A., Nelde A., Walz j., Krause G., Baillot A., Schenke-Layland K., Joos TO., Rothbauer U., Schneiderhan-Marra N., Schindler M., Templin MFACS Infectious Diseases 2021; https://doi.org/10.1021/acsinfecdis.0c00725.
-
Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivityBecker M, Strengert M, Junker D, Kaiser P, Kerrinnes T, Traenkle B, Dinter H, Häring J, Ghozzi S, Zeck A, Weise F, Peter A, Hörber S, Fink S, Ruoff F, Dulovic A, Bakchoul T, Baillot A, Lohse S, Cornberg M, Illig T, Gottlieb J, Smola S, Karch A, Berger K, Rammensee HG, Schenke-Layland K, Nelde A, Märklin M, Heitmann JS, Walz JS, Templin M, Joos TO, Rothbauer U, Krause K & Schneiderhan-Marra NNATURE COMMUNICATIONS | (2021) 12:1152 | https://doi.org/10.1038/s41467-021-20973-3 | www.nature.com/naturecommunications
-
Magnetic Bead-Based Immunoassay Allows Rapid, Inexpensive, and Quantitative Detection of Human SARS-CoV-2 AntibodiesHuergo LF, Selim KA, Conzentino MS, Gerhardt ECM, Santos ARS, Wagner B, Alford JT, Deobald N, Pedrosa FO, de Souza EM, Nogueira MB, Raboni SM, Souto D, Rego FGM, Zanette DL, Aoki MN, Nardin JM, Fornazari B, Morales HMP, Borges VA, Nelde A, Walz JS, Becker M, Schneiderhan-Marra N, Rothbauer U, Reis RA, Forchhammer KACS Sensors 2021, 6(3):703-708, https://doi.org/10.1021/acssensors.0c02544
-
NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune responseWagner T., Ostertag E., Kaiser P., Gramlich M., Ruetalo N., Junker D., Haering J., Traenkle B., Becker M., Dulovic A., Schweizer H., Nueske S., Scholz A., Zeck A., Schenke-Layland K., Nelde A., Strengert M., Walz J., Zocher G., Stehle T., Schindler M., Schneiderhan-Marra N., Rothbauer UIn EMBO Reports 2021; 22(5):e52325. https://doi.org/10.15252/embr.202052325
-
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognitionNelde A., Bilich T., Heitmann JS., Maringer Y., Salih HR., Roerden R., Luebke M., Bauer J., Rieth J., Wacker M., Peter A., Hörber S., Traenkle B., Kaiser PD., Rothbauer U., Becker M., Junker D., Krause G., Strengert M., Schneiderhan-Marra N., Joos TO., Kowalewski D.J., Stos-Zweifel V., Fehr M., Graf M., Gruber L., Rachfalski D., Preuß B., Hagelstein I., Märklin M., Bakchoul T., Gouttefangeas C., Kohlbacher O., Klein R., Stevanović S., Rammensee H.-G., Walz J.S.Nature Immunology 2021; 22:74–85, DOI: https://doi.org/10.1038/s41590-020-00808-x